Table 4.

Visual, anatomical and survival outcomes

	Poor vision at last follow up (n=21)	P	Evisceration (n=5)	P	Patient who died (n=7)	P	NLP (n=12)	P
Good vision at initial visit n=11 (%)	3 (30)*	0.08	1 (9.1)	0.97	0	0.19	1 (9.1)*	0.20
Poor vision at initial visit n=25 (%)	16 (69.6)*		4 (16)		6 (24)*		9 (36.0)*
Fungal** n=13 (%)	10 (83.3)*	0.19	1 (7.7)	1.0	5 (38.5)	0.16	3 (23.1)	0.67
Bacteria** n=13 (%)	6 (54.5)		2 (15.4)		1 (7.7)		5 (38.5)
Culture positive n=26 (%)	16 (69.6)*	0.06	3 (11.5)	1.0	6 (23.1)	0.36	8 (30.8)	1.0
Culture negative n=15(%)	5 (38.5)*		2 (13.3)		1 (6.7)		4 (26.7)
Immuno-suppressed n=20(%)	14 (70.0)*	0.11	4 (20.0)	0.31	4 (20.0)	0.94	6 (30.0)	0.92
No Immunosuppression n=21(%)	7 (43.8)*		1 (4.8)		3 (14.3)		6 (28.6)

NLP- no light perception, *missing data- Initial vision could not be assessed among 3 eyes and final vision could not be assessed among 5 eyes. ** included only culture positive cases